Meipai Medical announced on the evening of September 23 that the company's actual controller and the concerted action parties of the controlling shareholder, Hol-Xinna Health Partners (Limited Partnership) and Hol-Xinna Tong Partners (Limited Partnership), intend to transfer a total of 3.8 million shares of the company's unrestricted circulation shares to Beijing Fengyan Ruiying No. 3 Private Equity Securities Investment Fund by agreement, accounting for 5.75% of the total share capital of the company, 5.78% of the total share capital after excluding the company's repurchased special account. The transfer price of the shares this time is 35.19 yuan/share, and the total transfer price is 0.134 billion yuan. Beijing Fengyan Ruiying No. 3 Private Equity Securities Investment Fund has committed not to reduce its shareholding in the company's shares acquired in this transaction within six months after the completion of the transfer.
迈普医学：实控人、控股股东的一致行动人拟协议转让380万股公司股份
Meipai Medical: The controlling shareholder and controlling shareholder's concerted action parties intend to transfer 3.8 million shares of the company's stock.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.